U.S. tariffs take center stage but China and the EU are quietly clashing

The European Union and China are experiencing rapidly escalating trade tensions, marked by reciprocal actions such as China's brandy tariffs—retaliating for EU EV duties—and mutual restrictions on medical device tenders. This intensification is driven by China's industrial overcapacity and export needs clashing with the EU's imperative to protect its domestic manufacturing, compounded by Beijing's perceived 'weaponization' of trade, including rare earth export controls. Experts characterize the relationship as 'quite poor,' forecasting continued turbulence and limited prospects for resolution, signaling sustained risks for global supply chains and affected industries.

Analysis

The trade relationship between the European Union and China is undergoing a significant deterioration, shifting from a partnership of opportunity to one defined by risk and strategic competition. The core of the conflict is a fundamental clash between China's economic need to export its industrial overcapacity amid sluggish domestic growth and the EU's objective to protect its domestic industrial base. This tension is escalating through reciprocal protectionist actions, exemplified by China's tariffs on EU brandy, which were a direct retaliation for EU levies on Chinese electric vehicles, and mutual curbs on market access for medical devices. Experts note that Beijing is increasingly 'weaponizing' trade, using tools like potential rare earth export controls as leverage. The expectation that U.S. tariffs might push the EU and China closer has not materialized; instead, analysts quoted in the article forecast further turbulence. The consensus outlook is pessimistic, with low expectations for a resolution at the upcoming EU-China Summit, signaling persistent and escalating trade frictions that will impact global supply chains and multinational corporations.

Key Decisions for Investors

• Investors should immediately review portfolio exposure to European sectors that are direct targets of Chinese retaliatory measures, such as luxury goods (specifically spirits like brandy), automotive manufacturers, and medical device companies.
• Given the structural nature of the conflict and the high market impact score, it is prudent to assess and potentially diversify supply chains for companies heavily reliant on either EU or Chinese manufacturing and inputs, particularly in sensitive sectors like automotive and energy that depend on rare earths.
• Monitor the upcoming EU-China Summit on July 24th for any signs of de-escalation or further hardening of positions, as the outcome will likely serve as a significant near-term catalyst for volatility in European equities and the EUR/CNH currency pair.